Safety and immunogenicity of sequential administration of PCV13 followed by PPSV23 in pneumococcal vaccine-naïve adults aged ≥ 65 years: Comparison of booster effects based on intervals of 0.5 and 1.0 year |
| |
摘 要: |
|
收稿时间: | 17 November 2022 |
本文献已被 ScienceDirect 等数据库收录! |
|